Anti-inflammatory, analgesic and immunomodulatory activity of RA ANTI-TNF-α — the active ingredient of Artrofoon and Kolofort drugs

  • G. R. Khakimova OOO «NPF "Materia Medica Holding"», Moscow, Russia
  • J. L. Dugina OOO «NPF "Materia Medica Holding"», Moscow, Russia
  • I. A. Ertuzun OOO «NPF "Materia Medica Holding"», Moscow, Russia
  • O. I. Epstein FSBSI "Institute of general pathology and pathophysiology", Moscow, Russia
Keywords: RA anti-TNFα, Artrofoon, Kolofort, specific pharmacological activity, safety, mechanism of action

Abstract

The article describes preclinical and clinical trial results (focusing on experimental data), that demonstrate broad spectrum of specific pharmacological activity and safety as well as mechanism of action for tumor necrosis factor α antibodies in release active form (RA anti-TNFα).

Published
2016-08-16
How to Cite
Khakimova, G. R., Dugina, J. L., Ertuzun, I. A., & Epstein, O. I. (2016). Anti-inflammatory, analgesic and immunomodulatory activity of RA ANTI-TNF-α — the active ingredient of Artrofoon and Kolofort drugs. Patogenez (Pathogenesis), 14(4), 22-29. Retrieved from https://pathogenesis.pro/index.php/pathogenesis/article/view/93
Issue
Vol. 14 No. 4 (2016): Pathogenesis
Section
Reviews